[Exam 1] Chapter 59: Assessment and Management of Patients with Male Reproductive Disorders Flashcards
(136 cards)
Cancer of Prostate: Most common cancer in men other than
nonmelanoma skin cancer
Cancer of Prostate: Who has the highest risk of prostate cancer?
Blacks, and twice as likely to die.
Cancer of Prostate: Risk factors for this?
Increasing age, and those who have father or brother previously diagnosed
Cancer of Prostate: Genes that may be associated with this?
HPC1 and BRCA1/BRCA2 mutations.
Cancer of Prostate: What diet increases chances of this
those with excessive amounts of red meat or datiry products high in fat.
Cancer of Prostate, CMs: What signs may happen if cancer is large enough?
Signs of urinary obstruction may occur. Also may be blood in urine.semen and painful ejaculation. Hematuria may occur in urethra invaded.
Cancer of Prostate, CMs: What is common before diagnosis made?
Sexual dysfunction
Cancer of Prostate, CMs: This can spread where?
To lymph nodes and bone.
Cancer of Prostate, CMs: Symptoms of metastases?
Backache, hip pain, perineal and rectal discomfort , anemia, weight loss, weakness, oliguria, and spontaneous pathologic fractures.
Cancer of Prostate, Assess/Diagnostic: How can this be diagnosed?
Through an abnormal finding with DRE, Serum PSA< and Ultrasound-guided TRUS with biopsy.
Cancer of Prostate, Assess/Diagnostic: Why is routine repeated DRE important?
Because early cancer may be detected as nodule within gland or as extensive hardening on posterior lobe.
Cancer of Prostate, Assess/Diagnostic: Diagnosis of prostate cancer confirmed how
by histologic exam of tissue removed surgically by TURP, prostatectomy or ultrasound-guided transrectal needle biopsy.
Cancer of Prostate, Assess/Diagnostic: Why is fine-needle aspiration great?
Because it is quick, painless method of obtaining prostate cells.
Cancer of Prostate, Assess/Diagnostic: When are most prostate cancers detected?
When man seeks medical attention for symptoms of urinary obstruction or found by routine DRE and PSA.
Cancer of Prostate, Assess/Diagnostic: What levles of DRE and PSA may arise suspicion?
Abnormal DRE and elevated levels of PSA
Cancer of Prostate, Assess/Diagnostic: What does TRUS help detect?
Nonpalpable prostate cancers and helps assist with staging localized prostate cancer. Needle biopsies of prostate guided by TRUS.
Cancer of Prostate, Assess/Diagnostic: Most commonly used tumor grading system?
Gleason score. Scores it 1-5 for most predominant pattern of glands and secondary grae of 1-5 to the second most predominant pattern. Lower scores indicate well-differentiated and less aggressive tumor cells.
Cancer of Prostate, Assess/Diagnostic: Categorization of low, intermediate, and high risk prostate cancer determined by what
extent of cancer in prostate gland, whether it is localized , aggressiveness of cells, and spread to lymph nodes.
Cancer of Prostate, Assess/Diagnostic: What may be used to identify metastatic bone disease?
Bone scans, skeletal x-rays, and MRI
Cancer of Prostate, Assess/Diagnostic: What can be done to see if its spread to lymph nodes?
Pelvic computed tomography (CT) scan.
Cancer of Prostate, Assess/Diagnostic: What antibody can eb used to detect either recurrent prostate cancer at low PSA levels or metastatic disease?
radiolabeled monoclonal antibody capromab pendetide with indium 111
Cancer of Prostate, Medical Mx: Treatment based on what?
Patients life expectancy, symptoms, risk of recurrent, size of tumor, and psa levels.
Cancer of Prostate, Medical Mx: What is done when a patient chooses a nonsurgical watchful waiting?
They actively monitor the course of disease and intervening only if cancer progresses. For those with less than 5 years to live.
Cancer of Prostate, Medical Mx: Advantage of nonsurgical watchful waiting?
Absence of SE, improved quality of life, and avoidance of unneccessary treatment.